SCI Financial Summary All currently active accounts through 31 May 2013

Prof. Alan Fenwick and Kieran Bird

Schistosomiasis Control Initiative Advisory Board Meeting 2013

SCI Account summary 1 OF 3 - Implementation

SCI Account summary (Implementation)31/05/2013

Account Funder StartDate

End Date

Award Name AwardExpended including

commitmentsBalance Expended

%

P10348 BMGF II 01/10/2006 31/12/2012 Integrated Health package £5,306,706 £5,243,704 £63,002 99%

P34831 DFID 01/10/2010 01/03/2016 NTD Treatment 8 countries £10,537,440 £7,336,731 £3,200,709 70%

P36980 Burundi 01/06/2011 01/05/2014Schistosomiasis and STH in Burundi £1,040,000 £768,897 £271,103 74%

P41895 END fund 01/03/2012 01/02/2015Rwanda Phase II programme £355,441 £340,647 £14,794 96%

    TOTAL   IMPLEMENTATION GRANTS £17,239,587 £13,689,979 £3,549,608 79%

SCI Account summary2 OF 3 – Operational research

SCI Account summary (Operational research)

31/05/2013

Account Funder StartDate

End Date

Award Name AwardExpended including

commitmentsBalance Expended

%

P36690BMGF/Univ Georgia 01/11/2010 01/10/2013 SCORE Niger Study 1 £186,345 £181,395 £4,950 97%

P32154BMGF/Univ Georgia 01/11/2010 01/10/2013 SCORE Niger Study 2 £370,386 £361,398 £8,988 98%

P32169BMGF/Univ Georgia 01/11/2010 01/10/2013

SCORE Mozambique Study £368,030 £318,152 £49,878 86%

P34213 BMGF 01/11/2010 01/10/2014 Control of Cysticercosis £957,372 £844,753 £112,619 88%

P43408 CIFF 01/11/2012 30/04/2014 Operational Research £508,500 £28,753 £479,747 6%

    TOTAL RESEARCH FUNDING £2,390,633 £1,734,450 £656,183 73%

SCI Account summary3 OF 3 – Unrestricted Funds

SCI Account summary (Unrestricted funds)

31/05/2013

Account Funder StartDate

End Date

Award Name AwardExpended including

commitmentsBalance Expended

%

L24009 Donations 01/11/2011 N/AUnrestricted private donations £2,269,311 £908,095 £1,361,216 40%

P10099 IC Trust 01/11/2006 N/A SCI Activities £362,883 £341,749 £21,134 94%

IC Trust reserves £198,999 £0 £198,999 0%

       TOTAL UNRESTRICTED FUNDS £2,831,192 £1,249,844 £1,581,348 44%

Implementation activities Gates 36202 award

Gates (#36202). Core funding for SCI (since 2006) and the evaluation of integrated control of Neglected Tropical Diseases in Africa

Total funds received US$ 9,975,810

Total interest £ 18,860

No cost extension 31 December 2012

Final report submitted Feb 2013

Unspent & unassigned available balance £70,334, SCI in discussion with BMGF to transfer to Cysticercosis award.

Implementation activities: DFID - Integrated Control of Schistosomiasis and Intestinal Helminths in sub-Saharan Africa (ICOSA)

SCI is service provider to the £25m DFID ICOSA programme to deliver 75 million treatments in 8 African countries (Crown Agents £14.5m SCI £10.5m) Awarded 2010.

The target is to reduce schistosomiasis and STH in selected African countries, working in close collaboration with national governments and other donor and international agencies involved in the control of NTDs.

A six year contract from October 2010 to March 2016.

SCI - £10.537 million (with Liverpool CNTD as sub)

Commodities (drugs and equipment) to be procured under the project will be up to £14.5 million (Crown Agents)

A total annual spend ceiling of £5 million

DFID - Integrated Control of Schistosomiasis and Intestinal Helminths in sub-Saharan Africa (ICOSA)

Overseas country budgets – FY4 (2013/14)

DFID - Integrated Control of Schistosomiasis and Intestinal Helminths in sub-Saharan Africa (ICOSA)Actual spend analysis by category, to 31 May 2013

DFID Phase II - Integrated Control of Schistosomiasis and Intestinal Helminths in sub-Saharan Africa (ICOSA)

Phase II In January 2012 DFID announced their intention to award additional funding for ICOSA from 2013 – The timetable is :

DFID appointed consultants are currently finalising the business case, to be submitted to the Secretary of State (by Sept 2013).

We have proposed (subject to negotiation)

If approved the new target will be over 200 million treatments in the existing 8 countries plus new programmes in Ethiopia and DRC

2013/14 2014/15 2015/16 2016/17 Total

SCI TOTAL £2,125,294 £3,604,538£4,327,89

0£6,567,92

1 £16,625,641TOTAL CROWN AGENTS £3,183,000 £2,983,000

£2,110,388 £97,971 £8,374,359

TOTAL £5,308,294 £6,587,538£6,438,27

7£6,665,89

2 £25,000,000

Implementation activitiesBurundi & Rwanda, Schisto & STH

Burundi

Funding is in place to continue the national treatment campaigns in Burundi for the next 3 years.

Total budget £1,040,000 plus Gift Aid, received via IC Trust

RwandaFunding is in place to continue the national treatment campaigns in Rwanda for the next 3 years from the ENDFUND

Total approved budget is US$1,643,507 over 3 years starting 01.03.12.

First tranche of funds received in the sum of US$450,000.

82% of these funds will go to the country for implementation.

Implementation - Burundi & Rwanda(as at May 31st 2013)

Burundi Rwanda

Operational Research SCI - SCORE – at University of Georgia (funded by Gates)

In January 2011, SCI were awarded three SCORE studies

TITLE: Studies of Gaining and Sustaining Control of Schistosomiasis

"Study: Schistosoma haematobium: Gaining and Sustaining Control of

Schistosomiasis in Capdelgado, Mozambique

"Study: Schistosoma haematobium: Gaining and Sustaining Control of

Schistosomiasis in Kollo and Say Districts, Niger

"Study: Schistosoma Haematobium: Gaining and Sustaining Control of

Schistosomiasis in Loga District, Niger

Research subcontracts have been executed with RISEAL Niger and Catholic University of Mozambique

Total Anticipated SCORE funds 2010 to 2015 - US$1.245 million.

Initial 3 year budget funding originally agreed, the final 2 year extensions for both countries are currently being finalised with SCORE.

Operational research SCI - SCORE – budget v actual cost, as 31 May 2013

Operational Research SCI – Gates, Control of Cysticercosis in sub Saharan Africa  

In November 2010, SCI, were awarded a BMGF contract:

TITLE: “Control of Cysticercosis in sub Saharan Africa”  

P.I. Dr Wendy Harrison

Total approved budget $1.3 million USD

Research subcontracts (90% total budget) have been executed;

•Technical University Munich, US$ 773,410

•Institute of Tropical Medicine Antwerp, US$ 141,375

•Univ. of Copenhagen, DBL (Danish Bilharziasis Laboratories), US$ 262,585

SCI (10% total budget) provide lead management function and M&E expertise.

Operational Research SCI – Gates, Control of Cysticercosis in sub Saharan Africa  

Budget v actual By category

Operational Research CIFF Childrens Investment Fund Foundation. Operational research in Liberia & Uganda 

In November 2012, SCI, were awarded a 3 year contract from CIFF:

TITLE: To assist the development of WHO policy regarding the delivery of deworming control programmes on Uganda, Liberia and Malawi.

P.I.s Prof Joanne Webster & Dr Wendy Harrison

The start date was 1st November 2012.

The agreed budget is £1,110,000 for 3 years.

The first 18 months (Nov12-Apr14) approved budget is £508,500

To be reviewed with regards to renewal/extension.

SCI have recently agreed re-aligned framework milestones and timeframe.

Operational Research CIFF,   CIFF Childrens Investment Fund Foundation. Operational research in Liberia & Uganda

Budget v actual, as 31 May 2013

Other awards/donations

• SCI receives some donations into IC Trust. SCI then draws down the funds into an account P 10099 by submitting proposals to the IC Trustees

P10099 budget v actual, 31 May 2013

Imperial College Trust (formerly Queen’s Gate Trust) is a registered charity (Registered Charity number 273071)

In addition to the above available funds, SCI has reserves in the sum of £198,999 available to draw down from the Trust

Other awards/donations

• Imperial College has provided SCI with another account ( L24009 ) specifically for private donations received direct to IC. To date some £2.26 million of unrestricted private donations have been received into this account since it was set-up in Feb 2012. SCI claims Gift Aid where allowable.

• These unrestricted funds have been used mainly for small scale interventions or “seed money” in emerging countries e.g. Mozambique, Mauritania, Niger, Senegal & Cote D’Ivoire. In addition, £500,000 has been ring-fenced for activity commitments in Ethiopia.

The donations include

• 2 x $250,000 donations from an US Foundation “Good Ventures”

• The first of 5 annual anonymous private donations (via IC Trust) for Ethiopia implementation in the sum of £100,000 per annum for 5 years

• Over $500,000 sent from Givewell for the second year running – via IC Foundation in USA

• Monthly bankers orders from over 300 people bringing in approximately £10,000 per month

Other awards/donations

Awards currently in the pipeline or being set-up include:

•END fund – Yemen, SCI have been awarded a grant for $150,000 for 2013 to support the national Mass Drug Administration program in Yemen

• VITOL – have awarded SCI $130,000 for Cote D'Ivoire, integrated mapping & ICT activities.

•NTDs were highlighted on Red Nose Day in March 2013, and so Comic Relief may award their first ever grant to control NTDs

•Sightsavers, have signed a technical assistance agreement for £85,000

•SCI has assisted Sightsavers win a £10 million award from DFID for NTD control in Northern Nigeria.

•SCI is also assisting Sightsavers with work in mapping schisto and STH in N. Nigeria

Publicity and advocacy

• SCI has so far retained its position as a top rated charity by “Giving what we can”www.givingwhatwecan.org

• SCI is one of the top three international charities recommended by www.givewell.org in USA (they review their recommendation annually)

• These recommendations have highlighted SCI internationally, illustrated financial transparency and led to increased donations. See recent Guardian article

• http://www.guardian.co.uk/voluntary-sector-network/2013/jun/11/charity-evaluators-assess-charities

• However it is imperative for the future of SCI that we continue to perform and be transparent if we want to retain our recommendations from these evaluation sites.

Finally…

Please see our newsletter at

http://www3.imperial.ac.uk/schisto/newsroom/newsletter

and a promotional video at

http://www3.imperial.ac.uk/schisto/whatwedo/audiovideo

Thank you